FDA.reportPublic FDA data

Xelstrym 18 MG in per HR Transdermal System

RxCUI
2624715
RxNorm name
Xelstrym 18 MG in per HR Transdermal System
Display name
Xelstrym 18 MG in per HR Transdermal System
Full name
Xelstrym 18 MG in per HR Transdermal System
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:46

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0862f02a-72a8-41cc-8845-57cf4974bb6fXelstrym 18 MG in 9 HR Transdermal System [PSN] · 9 HR dextroamphetamine 2 MG/HR Transdermal System [Xelstrym] [SBD] · 9 HR Xelstrym 2 MG/HR Transdermal System [SY] · Xelstrym 18 MG in per HR Transdermal System [SY]417These highlights do not include all the information needed to use XELSTRYM safely and effectively. See full prescribing information for XELSTRYM. XELSTRYM ® (dextroamphetamine) transdermal system, CII Initial U.S. Approval: 197520251223